Discontinuation report ABILIFY

Last updated on 2021-05-01 History
Report ID 129991
Drug Identification Number 02322390
Brand name ABILIFY
Common or Proper name ARIPIPRAZOLE
Company Name OTSUKA PHARMACEUTICAL CO LTD
Market Status MARKETED
Active Ingredient(s) ARIPIPRAZOLE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size BLISTER format only
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-04-30
Actual discontinuation date 2021-04-30
Remaining supply date 2021-04-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Samples in blister format are available until the discontinuation date.
Company comments ONLY BLISTER (sample) format is discontinued. The bottle format is still available.
Health Canada comments
Contact Address 2-9 KANDA-TSUKASAMACHI
CHIYODA-KU TOKYO, --
JAPAN 101-8535
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-05-01 English Compare
v2 2020-12-10 French Compare
v1 2020-12-10 English Compare